A TREM2 independent pathway is thus proposed to initiate Apoe upregulation in the early phase of AD, with a later TREM2‐dependent pathway activating Apoe transcription which induces neurodegenerative microglia. The gene discussed is APOE; the disease is Alzheimer disease.